Evidence map›Paper›PMID 29307989›Full record

ArticleWorld journal of gastroenterology2017

Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing.

Omar Youssef, Virinder Sarhadi, Homa Ehsan, Tom Böhling, Monika Carpelan-Holmström, Selja Koskensalo, Pauli Puolakkainen, Arto Kokkola, Sakari Knuutila

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. The frequency of NRAS mutation in stool samples of Iranian colorectal cancers compared to Finnish patients.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2024
    Article
  4. Network approach in liquidomics landscape.Journal of experimental & clinical cancer research : CR · 2023
    Review
  5. Article
  6. Circulating tumour DNA - looking beyond the blood.Nature reviews. Clinical oncology · 2022
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Omar YoussefDepartment of Pathology, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland.
Virinder SarhadiDepartment of Pathology, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland.
Homa EhsanDepartment of Pathology, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland.
Tom BöhlingDepartment of Pathology, University of Helsinki and HUSLAB, Helsinki University Hospital, Helsinki 00014, Finland.
Monika Carpelan-HolmströmThe HUCH Gastrointestinal Clinic, University Central Hospital of Helsinki, Helsinki 00290, Finland.
Selja KoskensaloThe HUCH Gastrointestinal Clinic, University Central Hospital of Helsinki, Helsinki 00290, Finland.
Pauli PuolakkainenThe HUCH Gastrointestinal Clinic, University Central Hospital of Helsinki, Helsinki 00290, Finland.
Arto KokkolaThe HUCH Gastrointestinal Clinic, University Central Hospital of Helsinki, Helsinki 00290, Finland.
Sakari KnuutilaDepartment of Pathology, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland. sakari.knuutila@helsinki.fi.
University of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo study cancer hotspot mutations by next-generation sequencing (NGS) in stool DNA from patients with different gastrointestinal tract (GIT) neoplasms.

methodsStool samples were collected from 87 Finnish patients diagnosed with various gastric and colorectal neoplasms, including benign tumors, and from 14 healthy controls. DNA was isolated from stools by using the PSP

resultsNGS was successful in assaying 72 GIT samples and 13 healthy controls, with success rates of the assay being 78% for stomach neoplasia and 87% for colorectal tumors. In stool specimens from patients with gastric neoplasia, five hotspot mutations were found in

conclusionOur results show that in addition to colorectal neoplasms, mutations can also be assayed from stool specimens of patients with gastric neoplasms.

Indexed as

FecesAdultAgedAged, 80 and overColorectal NeoplasmsDNADNA Mutational AnalysisEarly Detection of CancerFemaleFinlandHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedMutationStomach NeoplasmsDNAColorectal neoplasiaGastric neoplasiaMutationsNext-generation sequencingStool DNA

Identifiers

PMID29307989
PMCPMC5743500
OpenAlexW2777650023

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.